日本調剤(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 小売業 | 3341/E05422 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/03/29 | 日証協 | 160,040株 | +21.87% | 214,945株 | +214.12% | 212,058株 | +10.5% | 55,647株 | +1257.24% |
2019/03/22 | 日証協 | 131,322株 | +5.71% | 68,427株 | -8.41% | 191,911株 | +14.5% | 4,100株 | -90.14% |
2019/03/15 | 日証協 | 124,234株 | -8.86% | 74,712株 | -44.14% | 167,615株 | -2.59% | 41,600株 | +106.97% |
2019/03/08 | 日証協 | 136,312株 | +6.68% | 133,747株 | +142.91% | 172,071株 | -5.86% | 20,100株 | -10.6% |
2019/03/01 | 日証協 | 127,782株 | -7.35% | 55,060株 | +18.08% | 182,775株 | -2.92% | 22,483株 | +174.18% |
2019/02/22 | 日証協 | 137,916株 | -0.25% | 46,628株 | +88.32% | 188,274株 | -6.1% | 8,200株 | +68.31% |
2019/02/15 | 日証協 | 138,265株 | -15.94% | 24,760株 | +18.96% | 200,502株 | -11.63% | 4,872株 | -70.83% |
2019/02/08 | 日証協 | 164,478株 | -21.08% | 20,813株 | -84.63% | 226,902株 | -21.81% | 16,700株 | -63.54% |
2019/02/01 | 日証協 | 208,418株 | +34.83% | 135,405株 | +30.4% | 290,205株 | +14.21% | 45,800株 | -12.87% |
2019/01/25 | 日証協 | 154,580株 | -7.36% | 103,836株 | +102.51% | 254,107株 | -3.54% | 52,564株 | +330.85% |
2019/01/18 | 日証協 | 166,858株 | +2.14% | 51,274株 | -35.78% | 263,427株 | +3.09% | 12,200株 | -43.26% |
2019/01/11 | 日証協 | 163,361株 | -10.11% | 79,847株 | +148.16% | 255,527株 | +0.2% | 21,500株 | +330% |
2019/01/04 | 日証協 | 181,736株 | +0.9% | 32,175株 | -28.28% | 255,018株 | +1.44% | 5,000株 | -15.25% |
2018/12/28 | 日証協 | 180,114株 | +14.11% | 44,859株 | -38.71% | 251,396株 | +0.39% | 5,900株 | -65.58% |
2018/12/21 | 日証協 | 157,836株 | +8.38% | 73,191株 | +30.34% | 250,418株 | +1.19% | 17,140株 | +20.59% |
2018/12/14 | 日証協 | 145,636株 | +0.96% | 56,154株 | +106.04% | 247,478株 | +4.44% | 14,213株 | -59.21% |
2018/12/07 | 日証協 | 144,251株 | +2.64% | 27,254株 | +25.08% | 236,965株 | +5.04% | 34,846株 | +44.59% |
2018/11/30 | 日証協 | 140,540株 | +6.58% | 21,789株 | -30.24% | 225,585株 | +3.9% | 24,100株 | +234.72% |
2018/11/22 | 日証協 | 131,864株 | +35.8% | 31,235株 | +15.12% | 217,123株 | +3.08% | 7,200株 | -45.36% |
※株式分割は考慮していませんのでご注意ください。
Page Top